Related Experiment Video
Updated: Jun 14, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.7K
Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from
Matteo Valerio1, Alessandro Inno1, Alberto Zambelli2
1Medical Oncology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.
Cancers
|August 29, 2024
Summary
A new deep neural network method, D3NS, stratifies tumors by somatic mutations, identifying subtypes linked to survival and clinical outcomes for precision medicine.
Area of Science:
- Oncology
- Bioinformatics
- Computational Biology
Background:
- Tumor subtype identification is crucial for precision medicine, enabling accurate diagnoses and personalized cancer therapies.
- Somatic mutations drive cancer development, altering tissue function and morphology.
- Current stratification methods can be enhanced by integrating deep learning with network analysis.
Purpose of the Study:
- To propose a novel deep neural network integrated into a network-based stratification framework (D3NS) for tumor stratification based on somatic mutations.
- To leverage deep learning to uncover hidden patterns in genomic data within gene interaction networks.
- To validate the D3NS method using real-world cancer data.
Main Methods:
- Developed the Deep Neural Network integrated into a Network-based Stratification framework (D3NS).
- Integrated gene interaction network knowledge with deep neural network capabilities.
- Applied D3NS to The Cancer Genome Atlas (TCGA) datasets for bladder, ovarian, and kidney cancers.
Main Results:
- Successfully stratified tumors into distinct subtypes based on somatic mutation profiles.
- Identified tumor subtypes associated with significantly different survival rates.
- Demonstrated significant associations between identified subtypes and clinical outcomes like tumor stage, grade, and therapy response.
Conclusions:
- D3NS offers a powerful computational tool for tumor stratification using somatic mutation data.
- The method can serve as a foundational model in cancer research.
- D3NS holds potential for clinical applications, aiding in personalized cancer treatment strategies.

